Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease
Article first published online: 22 AUG 2008
© 2008 THE AUTHORS. JOURNAL COMPILATION © 2008 BJU INTERNATIONAL
Volume 102, Issue 11, pages 1539–1543, December 2008
How to Cite
Guzzo, T. J., Rogers, C. G., Deng, C. Y., Bivalacqua, T. J., Palapattu, G. S., Bastian, P. J., Eisenberger, M. A., Schoenberg, M. P. and Gonzalgo, M. L. (2008), Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease. BJU International, 102: 1539–1543. doi: 10.1111/j.1464-410X.2008.07877.x
- Issue published online: 21 NOV 2008
- Article first published online: 22 AUG 2008
- Accepted for publication 14 May 2008
- bladder cancer;
- radical cystectomy;
To assess the clinical outcome of patients with bladder cancer who underwent attempted radical cystectomy (RC) with curative intent, but whose procedures were aborted due to intraoperative findings of metastatic disease, as the presence of metastatic disease at RC is associated with a poor prognosis and there are no data on the optimum management strategy in this situation.
PATIENTS AND METHODS
In all, 248 consecutive patients with bladder cancer had attempted RC at one academic institution between 1994 and 2003. We retrospectively reviewed the records of 35 patients who had an aborted RC due to intraoperative findings of metastatic disease. The pathological characteristics, time to recurrence, overall survival, disease-specific survival, and suitability for adjuvant or salvage therapies were examined.
Of the 35 patients who had an aborted RC for metastatic disease, 21 (60%) died from the disease within the study period (median time to cancer-specific death 26.4 months), 11 (31%) are alive with evidence of persistent disease or progression, and three (9%) are alive with no evidence of recurrence or progression. Seven patients had a salvage RC after successful adjuvant treatment, of whom three died from recurrent disease (at a mean of 46.5 months after initial exploration, 31.9 months after salvage RC), one is alive with bladder cancer recurrence to the rectum 10 months after salvage cystectomy, and three have no evidence of disease progression at a mean of 10 months after salvage RC.
The prognosis of patients who undergo an aborted attempt at curative RC due to intraoperative findings of metastatic disease is poor. Although a few patients might subsequently have salvage RC, many of these patients still have poor outcomes even if adjuvant treatments are used. When metastatic disease is discovered at RC, completing the cystectomy should be considered, although further studies are needed to show a clinical benefit.